The menopause conversation often centers on the ovaries and declining estrogen. But one of the body’s largest and most metabolically active endocrine organs, skeletal muscle, plays a critical role in how women experience this transition.
Skeletal muscle does far more than support mobility and strength. Through the release of bioactive molecules called myokines, it influences glucose metabolism, inflammatory signaling, and cardiovascular health. As estrogen declines during perimenopause and menopause, preserving muscle mass becomes one of the most impactful and modifiable strategies for metabolic resilience.
For integrative medicine practitioners, hormone testing offers insight into these physiologic changes. Interpreted alongside lifestyle factors and body composition, laboratory data can help identify women at increased risk for muscle loss, insulin resistance, and accelerated cardiometabolic decline.
Estrogen Decline and the Hidden Cost of Muscle Loss
Menopausal sarcopenia, the accelerated loss of skeletal muscle mass and strength, is one of the lesser known consequences of menopause. Estrogen plays a role in supporting muscle protein synthesis, mitochondrial function, and reduced protein breakdown by acting on estrogen receptors within muscle tissue. When circulating 17 β-estradiol falls, these protective effects diminish alongside the progressive loss of lean mass, reduced strength, function, and metabolic flexibility.
Menopausal sarcopenia often begins during perimenopause before it shows up on the scale. Patients may instead notice slower recovery, increased fatigue, or body composition changes despite unchanged habits.
Hormone testing during this transition can reveal falling estrogen levels, helping clinicians identify women who may benefit from resistance training, adequate dietary protein, and lean mass-preserving strategies before significant muscle loss sets in.
Muscle Mass Influences More Than Strength
Emerging research links the loss of lower skeletal muscle mass to more severe menopausal symptoms, including vasomotor symptoms, sleep disturbance, fatigue, and mood changes likely mediated through muscle’s effects on systemic inflammation and metabolic health.
As a result, women with significant vasomotor symptoms and/or poor sleep may also benefit from evaluation of body composition, nutritional status, and metabolic health to support muscle preservation as an adjunctive strategy alongside hormone testing and other evidence-based interventions.
Skeletal Muscle: The Body’s Largest Metabolic Sink
Skeletal muscle handles roughly 80% of insulin-stimulated glucose disposal, making it a primary regulator of blood glucose. Menopause complicates this: declining estrogen alters estrogen receptor-α (ERα) signaling in muscle, reducing insulin sensitivity and increasing visceral adiposity - contributors to the sharp rise in metabolic syndrome and type 2 diabetes seen after menopause.
The good news: postmenopausal muscle has been shown to be highly responsive to exercise. Resistance and high-intensity training significantly improve insulin sensitivity and glucose uptake in postmenopausal women, regardless of estrogen status.
Muscle Functions as an Endocrine Organ
One of the most exciting developments in menopause research is the recognition that skeletal muscle itself functions as an endocrine organ. During exercise, contracting muscle releases myokines - signaling molecules that influence immune regulation, lipid metabolism, insulin sensitivity, and even brain health.
One emerging myokine, Meteorin-like (METRNL), shows potential anti-inflammatory and metabolic effects. Resistance training has been shown to raise circulating levels of several beneficial myokines in postmenopausal women suggesting exercise-induced muscle activity may partially offset the loss of estrogen’s protective effects. This reframes resistance training as more than a strength strategy because each session triggers signaling that supports cardiovascular and metabolic health during a period of major endocrine change.
So, if muscle is driving this much of the metabolic and symptomatic picture, what can be measured to inform your treatment plan?
What Laboratory Testing Can Reveal
Muscle mass itself can’t be measured with hormone testing, but endocrine biomarkers can reveal patterns driving declining lean mass, impaired recovery, and metabolic dysfunction. A comprehensive evaluation may cover:
-
Sex hormone status - Declining estrogen and androgens can affect muscle protein synthesis and body composition
-
Cortisol/HPA Axis patterns - Both chronic elevation and a flattened diurnal rhythm are linked to impaired muscle recovery, visceral adiposity, and insulin resistance
-
Metabolic markers - Glucose regulation and insulin sensitivity often begin declining in perimenopause
-
Hormone metabolism - Estrogen production, clearance, and downstream pathways may contribute to symptom presentation
Viewed alongside nutrition, exercise, and body composition, this data helps clinicians personalize interventions for muscle preservation and metabolic health.
Beyond Resistance Training: Three Evidence-Based Additions
While resistance exercise remains the cornerstone of muscle preservation in menopause, here are three additional, evidence backed interventions worth discussing with patients:
-
Post-prandial walking. A 10-20 minute walk after meals stimulates insulin-independent glucose uptake in muscle, acting as an immediate “glucose sink”. Studies consistently show post-meal walking reduces glucose excursions and improves glycemic control versus prolonged sitting, a low barrier complement to resistance training for improved glucose disposal.
-
Creatine. Beyond its athletic reputation, creatine supports ATP regeneration in muscle, improving training capacity and recovery. In menopause, supplementation combined with resistance training enhances gains in lean mass, strength, and physical performance; and there’s emerging evidence for its role in cognitive function, fatigue, and mood. Current evidence supports 3-5 g / day of creatine monohydrate alongside resistance exercise.
-
Urolithin A. A post biotic produced after the consumption and supplementation of polyphenols, Urolithin A has been shown in human clinical trials to improve muscle strength and endurance in middle aged and older adults with daily supplementation of 500mg to 1000mg.
Muscle Doesn’t Work Alone - Neither Do Hormones
Hormones rarely act in isolation: estrogen influences muscle, muscle influences insulin sensitivity, insulin affects inflammation. Chronic stress via the HPA axis can disrupt each of these pathways, potentially compounding the muscle and metabolic changes already underway in menopause.
Comprehensive hormone and HPA axis assessment can add valuable context for patients presenting with fatigue, difficulty maintaining muscle, progressive central weight gain, worsening insulin resistance, slower recovery, heightened stress reactivity, or persistent vasomotor symptoms. Read alongside nutrition, activity, and body composition; testing can support individualized strategies for healthy aging, rather than simply reacting to hormone decline.
